Repligen | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Agilent USD 899M 18M 2025-01
Align Technology USD 680.11M 16.83M 2025-03
Bio Techne USD 196.58M 8.66M 2024-12
BioMarin Pharmaceutical USD 611.17M 53.89M 2024-12
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Bruker USD 493.3M 74.5M 2024-12
Charles River Laboratories USD 319.68M 48.09M 2024-12
Danaher USD 3.53B 364M 2025-03
Dentsply International USD 455M 40M 2024-12
Exact Sciences USD 429.29M 83.29M 2024-12
General Electric USD 3.73B 102M 2025-03
Henry Schein USD 993M 0 2024-12
Illumina USD 728M 17M 2024-12
IQVIA Holdings USD 1.38B 0 2024-12
Mettler Toledo International USD 639.31M 66.85M 2024-12
Myriad Genetics USD 150.9M 1.1M 2024-12
Pfizer USD 11.12B 987M 2025-03
Repligen USD 90.76M 10.44M 2025-03
Revvity USD 375.55M 36.74M 2025-03
Standard Biotools USD 21.9M 1.36M 2024-12
Thermo Fisher Scientific USD 4.31B 514M 2025-03
Waters USD 524.2M 85.55M 2024-12
West Pharmaceutical Services USD 231.9M 41.7M 2025-03



Repligen Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.